You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 2
  • 629-D The anti-tumor activity of IFNβ and membrane-stable CD40L expressing oncolytic virus MEM-288 in NSCLC patients is associated with modulation of the tumor microenvironment and systemic immune response

Article metrics

Article menu

Download PDFPDF

Regular Abstracts – Part 2
Clinical Trial Completed
629-D The anti-tumor activity of IFNβ and membrane-stable CD40L expressing oncolytic virus MEM-288 in NSCLC patients is associated with modulation of the tumor microenvironment and systemic immune response

 

Online download statistics by month:

Online download statistics by month: October 2023 to July 2025

AbstractFullPdf
Oct 2023400
Nov 2023126011
Dec 20234708
Jan 20243603
Feb 20245204
Mar 20242203
Apr 20242003
May 20241601
Jun 20241000
Jul 2024803
Aug 20241002
Sep 20244205
Oct 202422010
Nov 20242005
Dec 20241205
Jan 20251404
Feb 2025303
Mar 2025008
Apr 2025001
May 2025005
Jun 2025006
Jul 2025001
Total464091